After getting a 15-fold return on his investment in mRNA research, Bill Gates has changed his position and now considers the technology to be subpar.
Before making a dramatic about-face and proceeding to publicly cast doubt on the entirety of mRNA technology, Bill Gates’ foundation made a perfectly timed investment in BioNTech, which was the partner of Pfizer for its mRNA Covid shots. As a result, Bill Gates was able to secure several hundred million dollars in profits from the investment, which were then donated to charity.
Reviewing the SEC filings, The Dossier discovered that the Gates Foundation’s holdings in BioNTech decreased from 1,038,674 to 148,674 shares during the 3rd quarter of 2021. This represented a reduction of 86 percent of shares owned by the Gates Foundation in the mRNA vaccine maker.
The Gates Foundation was able to acquire its stock in the Pfizer vaccination partner via a pre-IPO stock agreement in Sept of 2019, only a few months before widespread panic over Covid began to spread throughout the globe. The acquisition price of each share was set at $18.10.
As you can see in the following image, Bill Gates was able to sell his shares in BioNtech during the company’s most successful fiscal quarter because of his impeccable market timing.
Given that the shares were sold at an average price of around $300 each during the third quarter of 2021, this indicates that Gates Foundation was able to collect approximately $260 million in cash proceeds from the sale. Of this amount, approximately $242 million was untaxed profit due to the fact that the funding was invested thru the foundation.
In addition, this does not take into consideration the extra 2 million shares from the Gates Foundation’s first pre-IPO equity investment that were sold prior to this time by the foundation. The Gates Foundation was able to earn a return that was nearly 15 times greater than its original investment via the sale that took place in Q3 2021.
In the next three months, Bill Gates sold 1.4 million shares in Curevac, which is another mRNA firm situated in Germany. Curevac has collaborated with other mRNA shot producers, and Gates made approximately $50 million from the transaction.
After selling his stakes in the mRNA firm, Bill Gates revised his opinion of the technology that underpins the “miracle cure.” In the past, Bill Gates has said that immunization with mRNA injections had a preventative impact and “helps your heart.” More recently, however, he has begun to condemn the experimental injections.
In Nov of 2021, after disposing of 86 percent of the BioNTech bag he was carrying, Bill Gates made the startling declaration that “we need a new method of administering the vaccinations.”
In direct contradiction to the claims he had made in all of his earlier interviews, in which he maintained that the injections were safe and dramatically reduced the risk of transmission, Gates said that “We didn’t have immunizations that prevent transmission.” “We got vaccinations that help people with overall health, but they just minimally lessen the transmission.”
And only the week before, Bill Gates ratcheted up his discourse of skepticism over mRNA, further distancing himself from the once-hyped technology that he used to gain hundreds of millions of dollars in epidemic profits.
“We also need to fix the three problems of [mRNA] vaccines,” Gates said in an interview with an Australian think tank. “The current vaccines are not infection blocking. They’re not broad, so when new variants come up you lose protection, and they have a very short duration, particularly in the people who matter, which are old people.”
As far as we’re aware, Bill Gates never has made a public statement on the cash out of his BioNTech investment.
Free Speech and Alternative Media are under attack by the Deep State. Real News Cast needs reader support to survive.
Every dollar helps. Contributions help keep the site active and help support the author (and his medical bills)
Please Contribute via GoGetFunding
